- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Cipla reappoints Umang Vohra as MD, Global CEO
New Delhi: Pharma major Cipla on Tuesday said its board has approved the re-appointment of Umang Vohra as the Managing Director and Global CEO of the company for a further period of five years.The board of directors has considered and approved the re-appointment of Umang Vohra, Managing Director, designated as ''Managing Director and Global Chief Executive Officer'' of the company, for a...
New Delhi: Pharma major Cipla on Tuesday said its board has approved the re-appointment of Umang Vohra as the Managing Director and Global CEO of the company for a further period of five years.
The board of directors has considered and approved the re-appointment of Umang Vohra, Managing Director, designated as ''Managing Director and Global Chief Executive Officer'' of the company, for a further period of five years w.e.f. April 1, 2021 to March 31, 2026, Cipla said in a regulatory filing.
Vohra had joined Cipla in 2015 and has been the MD & Global CEO of the company since September 1, 2016, it added.
Read also: Cipla to support Terra Carta, for sustainable future
"As Cipla''s MD & GCEO, Vohra''s priorities have been Cipla''s strategic growth, defining and executing Cipla''s roadmap to maintain momentum in home markets whilst strengthening its presence in other regions, consolidating its core focus areas, augmenting capability, and building the right organisation," the filing said.
After gaining degrees in engineering, marketing and finance, Vohra worked with Eicher Motors, PepsiCo and Dr Reddy''s Laboratories, it added.
Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751